Carregant...
Somatostatin receptor 2 targeting in small cell lung carcinoma: perspectives
Small Cell lung carcinoma (SCLC) is the most lethal and aggressive subtype of lung cancer. Novel targeting approaches and agents are desperately needed. In this perspectives, we briefly explore recent data published in the International Journal of Cancer suggesting Somatostatin Receptor 2 (SSTR2) as...
Guardat en:
| Publicat a: | Oncotarget |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Impact Journals LLC
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6677662/ https://ncbi.nlm.nih.gov/pubmed/31413814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27107 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|